The latest price target for PROCEPT BioRobotics (NASDAQ:PRCT) was reported by Morgan Stanley on February 26, 2025. The analyst firm set a price target for $95.00 expecting PRCT to rise to within 12 months (a possible 56.77% upside). 16 analyst firms have reported ratings in the last year.

The latest analyst rating for PROCEPT BioRobotics (NASDAQ:PRCT) was provided by Morgan Stanley, and PROCEPT BioRobotics maintained their overweight rating.

There is no last upgrade for PROCEPT BioRobotics

There is no last downgrade for PROCEPT BioRobotics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PROCEPT BioRobotics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PROCEPT BioRobotics was filed on February 26, 2025 so you should expect the next rating to be made available sometime around February 26, 2026.

While ratings are subjective and will change, the latest PROCEPT BioRobotics (PRCT) rating was a maintained with a price target of $105.00 to $95.00. The current price PROCEPT BioRobotics (PRCT) is trading at is $60.60, which is out of the analyst’s predicted range.